KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) Other Operating Expenses (2016 - 2025)

Repligen (RGEN) has disclosed Other Operating Expenses for 16 consecutive years, with $92.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 29.82% to $92.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $338.4 million, a 6.97% decrease, with the full-year FY2025 number at $338.4 million, down 6.77% from a year prior.
  • Other Operating Expenses was $92.6 million for Q4 2025 at Repligen, up from $84.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $131.9 million in Q4 2024 to a low of $59.7 million in Q1 2021.
  • A 5-year average of $81.4 million and a median of $79.7 million in 2022 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: soared 90.52% in 2021, then decreased 29.82% in 2025.
  • Repligen's Other Operating Expenses stood at $87.9 million in 2021, then decreased by 16.31% to $73.6 million in 2022, then grew by 20.26% to $88.5 million in 2023, then surged by 49.07% to $131.9 million in 2024, then dropped by 29.82% to $92.6 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Other Operating Expenses are $92.6 million (Q4 2025), $84.1 million (Q3 2025), and $83.3 million (Q2 2025).